Intralenticular Ozurdex® – One Year Later
Reported here is a case of intralenticular sustained-release dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) present for 1 year with effective treatment of refractory diabetic macular edema without rapid cataract formation. The crystalline lens remained stable for 12 months on exam despi...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2017-12-01
|
| Series: | Case Reports in Ophthalmology |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/485318 |
| _version_ | 1818886725430149120 |
|---|---|
| author | Kathleen A. Regan Charles R. Blake Zachary L. Lukowski Siva S.R. Iyer |
| author_facet | Kathleen A. Regan Charles R. Blake Zachary L. Lukowski Siva S.R. Iyer |
| author_sort | Kathleen A. Regan |
| collection | DOAJ |
| description | Reported here is a case of intralenticular sustained-release dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) present for 1 year with effective treatment of refractory diabetic macular edema without rapid cataract formation. The crystalline lens remained stable for 12 months on exam despite the presence of the steroid-secreting foreign body. The diabetic macular edema resolved on exam and on optical coherence tomography. After 1 year, cataract extraction was uneventfully performed by phacoemulsification for a mild decline in visual acuity. Macular edema remains resolved 2 months following cataract removal. This is the longest reported period of observation of intralenticular Ozurdex in the literature. Ozurdex remains effective despite intralenticular location, and it can have minimal effects on cataract progression. |
| first_indexed | 2024-12-19T16:25:54Z |
| format | Article |
| id | doaj.art-6f99b7041c1e49059cc49158c116e3e3 |
| institution | Directory Open Access Journal |
| issn | 1663-2699 |
| language | English |
| last_indexed | 2024-12-19T16:25:54Z |
| publishDate | 2017-12-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Case Reports in Ophthalmology |
| spelling | doaj.art-6f99b7041c1e49059cc49158c116e3e32022-12-21T20:14:20ZengKarger PublishersCase Reports in Ophthalmology1663-26992017-12-018359059410.1159/000485318485318Intralenticular Ozurdex® – One Year LaterKathleen A. ReganCharles R. BlakeZachary L. LukowskiSiva S.R. IyerReported here is a case of intralenticular sustained-release dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) present for 1 year with effective treatment of refractory diabetic macular edema without rapid cataract formation. The crystalline lens remained stable for 12 months on exam despite the presence of the steroid-secreting foreign body. The diabetic macular edema resolved on exam and on optical coherence tomography. After 1 year, cataract extraction was uneventfully performed by phacoemulsification for a mild decline in visual acuity. Macular edema remains resolved 2 months following cataract removal. This is the longest reported period of observation of intralenticular Ozurdex in the literature. Ozurdex remains effective despite intralenticular location, and it can have minimal effects on cataract progression.https://www.karger.com/Article/FullText/485318Intralenticular dexamethasone implantation (Ozurdex®)Diabetic macular edemaNuclear sclerotic cataract |
| spellingShingle | Kathleen A. Regan Charles R. Blake Zachary L. Lukowski Siva S.R. Iyer Intralenticular Ozurdex® – One Year Later Case Reports in Ophthalmology Intralenticular dexamethasone implantation (Ozurdex®) Diabetic macular edema Nuclear sclerotic cataract |
| title | Intralenticular Ozurdex® – One Year Later |
| title_full | Intralenticular Ozurdex® – One Year Later |
| title_fullStr | Intralenticular Ozurdex® – One Year Later |
| title_full_unstemmed | Intralenticular Ozurdex® – One Year Later |
| title_short | Intralenticular Ozurdex® – One Year Later |
| title_sort | intralenticular ozurdex r one year later |
| topic | Intralenticular dexamethasone implantation (Ozurdex®) Diabetic macular edema Nuclear sclerotic cataract |
| url | https://www.karger.com/Article/FullText/485318 |
| work_keys_str_mv | AT kathleenaregan intralenticularozurdexoneyearlater AT charlesrblake intralenticularozurdexoneyearlater AT zacharyllukowski intralenticularozurdexoneyearlater AT sivasriyer intralenticularozurdexoneyearlater |